Morgan Stanley Biotechnology Team: Year-End Vaccine Probable

By J.P. Morgan Wealth Management There’s no shortage of worries batting around: the Fed is holding resolute on its...

STRATEGY: Stick with Epicenter in 2H2021. Strong markets stay strong. US COVID-19 deaths are “unvaccinated” Americans COVID-19 cases could...

Another difficult week for the large-cap indices like the S&P 500 (SPX) and Nasdaq Composite (COMPQ), which both fell...

There are a great many opinions on the market and the potential outcome/s for the debt ceiling that lay...

Burgeoning ‘green shoots’ bring hope for an economic recovery The last time I used the term “green shoots” was...

Despite all the uncertainty across today’s global capital markets, we are poised to enter 2023 with a more constructive...

When you feel like giving up, realize that at that very moment, you are at the same fork in...

  Cross-asset strategy: This week’s Fed reiteration that it won’t hike for about three years despite extraordinary fiscal stimulus...